DANIEL LEUNG to Cytochrome P-450 CYP3A Inhibitors
This is a "connection" page, showing publications DANIEL LEUNG has written about Cytochrome P-450 CYP3A Inhibitors.
Connection Strength
0.709
-
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3-11 Years with Hepatitis C Genotype 1a. Adv Ther. 2020 07; 37(7):3299-3310.
Score: 0.709
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.